UBS Maintains Neutral on ArcBest, Raises Price Target to $154
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $145 to $154.
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $145 to $154.